Systematic and random errors of PET-based 90 Y 3D dose quantification.
暂无分享,去创建一个
[1] D. Sze,et al. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[2] Firas Mourtada,et al. Dose volume histogram‐based optimization of image reconstruction parameters for quantitative 90Y‐PET imaging , 2018, Medical physics.
[3] S. Kappadath,et al. Hepatocellular Carcinoma Tumor Dose Response After 90Y-radioembolization With Glass Microspheres Using 90Y-SPECT/CT-Based Voxel Dosimetry. , 2018, International journal of radiation oncology, biology, physics.
[4] S. Cheenu Kappadath,et al. Comparison of Step-and-Shoot and Continuous-Bed-Motion PET Modes of Acquisition for Limited-View Organ Scans , 2017, The Journal of Nuclear Medicine Technology.
[5] Firas Mourtada,et al. Effects of image noise, respiratory motion, and motion compensation on 3D activity quantification in count-limited PET images , 2017, Physics in medicine and biology.
[6] S. Kappadath,et al. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models. , 2016, International journal of radiation oncology, biology, physics.
[7] S. Kappadath,et al. Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for 90Y microsphere selective internal radiation therapy , 2015, EJNMMI Physics.
[8] Maurizio Conti,et al. (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. , 2015, Medical physics.
[9] Michael Tapner,et al. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[10] J. Bouček,et al. A Gelatin Liver Phantom of Suspended 90Y Resin Microspheres to Simulate the Physiologic Microsphere Biodistribution of a Postradioembolization Liver , 2014, The Journal of Nuclear Medicine Technology.
[11] Matthew S. Johnson,et al. The Impact of Image Reconstruction Bias on PET/CT 90Y Dosimetry After Radioembolization , 2014, The Journal of Nuclear Medicine.
[12] F. Orsi,et al. Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective , 2014, Front. Oncol..
[13] A. Pasciak,et al. A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres , 2014, Front. Oncol..
[14] G. Sgouros,et al. Dosimetry for radiopharmaceutical therapy. , 2014, Seminars in nuclear medicine.
[15] D. Townsend,et al. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres , 2013, EJNMMI Research.
[16] K. Boudjema,et al. Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[17] Yannick Berker,et al. Study-Parameter Impact in Quantitative 90-Yttrium PET Imaging for Radioembolization Treatment Monitoring and Dosimetry , 2013, IEEE Transactions on Medical Imaging.
[18] C. Bodet-Milin,et al. Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT , 2013, EJNMMI Research.
[19] S. Jalkanen,et al. Nuclear imaging of inflammation: homing-associated molecules as targets , 2013, EJNMMI Research.
[20] Yuni K. Dewaraja,et al. MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy , 2012, The Journal of Nuclear Medicine.
[21] M. D’Arienzo,et al. 90Y PET-based dosimetry after selective internal radiotherapy treatments , 2012, Nuclear medicine communications.
[22] Y. Rolland,et al. Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results , 2012, The Journal of Nuclear Medicine.
[23] N. Lanconelli,et al. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions , 2012, Physics in medicine and biology.
[24] Wenzheng Feng,et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies. , 2011, Medical physics.
[25] Lidia Strigari,et al. Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations , 2010, The Journal of Nuclear Medicine.
[26] L. V. Elmbt,et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[27] V. Johnson,et al. Target definition of moving lung tumors in positron emission tomography: correlation of optimal activity concentration thresholds with object size, motion extent, and source-to-background ratio. , 2010, Medical physics.
[28] E. Cortesi,et al. Selective Internal Radiation Therapy with SIR-Spheres for the Treatment of Unresectable Colorectal Hepatic Metastases , 2009, CardioVascular and Interventional Radiology.
[29] S. Gulec,et al. Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio , 2007, Journal of Translational Medicine.
[30] M. D'Andrea,et al. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4. , 2006, Medical physics.
[31] G. van Hazel,et al. Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer , 2004, Journal of surgical oncology.
[32] Cedric X. Yu,et al. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. , 2004, Medical physics.
[33] C. Stearns,et al. Random coincidence estimation from single event rates on the Discovery ST PET/CT scanner , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).
[34] Kenneth G. Thurston,et al. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. , 2002, Journal of vascular and interventional radiology : JVIR.
[35] V. Gebski,et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] N. Pavlakis,et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. , 2012, Journal of vascular and interventional radiology : JVIR.